MultiCell Technologies Inc (MCET)

[murocman]

Anybody have any thoughts on reason for the big move and volume?

It looks like this company has been (and hopefully still is) associated with several heavy-hitter pharmaceutical companies such as Merck, Bristol-Meyers, etc in the past. However it doesn't look like much has gone on in the last year+.

Given that, I don't think you'd see this kind of move and volume just over optimisim on stem cells, especially given that this company focuses on adult stem cells from the liver, which hasn't been controversial.

My thought is that there is some yet-to-be announced development that is prompting all of the action.

Anybody have anymore insight?

Murocman